{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:18:02Z","timestamp":1787761082196,"version":"build-2784847793"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-04544-0","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T08:23:04Z","timestamp":1765268584000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Macroscopic growth patterns and their molecular implications in gastric carcinoma: toward risk stratification via borrmann classification"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3688-2768","authenticated-orcid":false,"given":"Gizem","family":"Issin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatih","family":"Demir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diren Vuslat","family":"Cagatay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irem Guvendir","family":"Bakkaloglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Gamsizkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeliha","family":"Yildiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismail","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevilay","family":"Ozmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itir Ebru","family":"Zemheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Demiriz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilyas","family":"Sayar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armagan","family":"Gunal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,9]]},"reference":[{"key":"4544_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"4544_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1615\/JEnvironPatholToxicolOncol.2023047662","volume":"42","author":"G Issin","year":"2023","unstructured":"Issin G, Sayar \u0130, Demir F, Bakkalo\u011flu \u0130G, Gamsizkan M, Yildiz Z, et al. Clinicopathologic features and prognostic significance of immunohistochemistry and in situ hybridization based molecular classification in gastric carcinoma. J Environ Pathol Toxicol Oncol. 2023;42:1\u201314.","journal-title":"J Environ Pathol Toxicol Oncol"},{"key":"4544_CR3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/apm.1965.64.1.31","volume":"64","author":"P Lauren","year":"1965","unstructured":"Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand. 1965;64:31\u201349.","journal-title":"Acta Pathol Microbiol Scand"},{"key":"4544_CR4","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1016\/j.ejso.2017.09.001","volume":"43","author":"J Lu","year":"2017","unstructured":"Lu J, Zheng CH, Cao LL, Li P, Xie JW, Wang JB, et al. The effectiveness of the 8th American Joint Committee on Cancer TNM classification in the prognosis evaluation of gastric cancer patients: a comparative study between the 7th and 8th editions. Eur J Surg Oncol. 2017;43:2349\u201356.","journal-title":"Eur J Surg Oncol"},{"key":"4544_CR5","first-page":"812","volume-title":"Handbuch der speziellen pathologichenanatomie und histologic","author":"R Borrmann","year":"1986","unstructured":"Borrmann R. Geschwulste Des Magens und Des Duodenums. In: Henke F, Lubarsch O, editors. Handbuch der speziellen pathologichenanatomie und histologic, vol. Vol. IV\/I. Berlin: Springer; 1986. p. 812\u20131054."},{"key":"4544_CR6","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1159\/000236018","volume":"77","author":"C Li","year":"2009","unstructured":"Li C, Oh SJ, Kim S, Hyung WJ, Yan M, Zhu ZG, et al. Macroscopic borrmann type as a simple prognostic indicator in patients with advanced gastric cancer. Oncology. 2009;77:197\u2013204.","journal-title":"Oncology"},{"key":"4544_CR7","doi-asserted-by":"crossref","unstructured":"D\u00edaz Del Arco C, Ortega Medina L, Estrada Mu\u00f1oz L, Molina Rold\u00e1n E, Cer\u00f3n Nieto M\u00c1, Garc\u00eda G\u00f3mez de Las Heras S, et al. Are Borrmann's Types of Advanced Gastric Cancer Distinct Clinicopathological and Molecular Entities? A Western Study. Cancers (Basel). 2021; 13: 3081","DOI":"10.3390\/cancers13123081"},{"issue":"1","key":"4544_CR8","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12957-016-0805-9","volume":"14","author":"Y Luo","year":"2016","unstructured":"Luo Y, Gao P, Song Y, Sun J, Huang X, Zhao J, et al. Clinicopathologic characteristics and prognosis of Borrmann type IV gastric cancer: a meta-analysis. World J Surg Oncol. 2016;14(1):49.","journal-title":"World J Surg Oncol"},{"issue":"7517","key":"4544_CR9","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/nature13480","volume":"513","author":"Cancer Genome Atlas Research Network","year":"2014","unstructured":"Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513(7517):202\u20139.","journal-title":"Nature"},{"issue":"7","key":"4544_CR10","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/modpathol.2016.55","volume":"29","author":"N Setia","year":"2016","unstructured":"Setia N, Agoston AT, Han HS, Mullen JT, Duda DG, Clark JW, et al. A protein and mRNA expression-based classification of gastric cancer. Mod Pathol. 2016;29(7):772\u201384.","journal-title":"Mod Pathol"},{"key":"4544_CR11","doi-asserted-by":"crossref","unstructured":"Lordick F, Carneiro F, Cascinu S, Fleitas T, Haustermans K, Piessen G, Vogel A, Smyth EC; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2022;33(10):1005\u20131020.","DOI":"10.1016\/j.annonc.2022.07.004"},{"issue":"3","key":"4544_CR12","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s00428-010-0952-2","volume":"457","author":"J R\u00fcschoff","year":"2010","unstructured":"R\u00fcschoff J, Dietel M, Baretton G, Arbogast S, Walch A, Monges G, et al. HER2 diagnostics in gastric cancer-guideline validation and development of standardized immunohistochemical testing. Virchows Arch. 2010;457(3):299\u2013307.","journal-title":"Virchows Arch"},{"issue":"7","key":"4544_CR13","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/j.1477-2574.2011.00326.x","volume":"13","author":"SC Mayo","year":"2011","unstructured":"Mayo SC, Shore AD, Nathan H, Edil BH, Hirose K, Anders RA, et al. Refining the definition of perioperative mortality following hepatectomy using death within 90 days as the standard criterion. HPB (Oxford). 2011;13(7):473\u201382.","journal-title":"HPB (Oxford)"},{"issue":"15","key":"4544_CR14","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1056\/NEJMsa012337","volume":"346","author":"JD Birkmeyer","year":"2002","unstructured":"Birkmeyer JD, Siewers AE, Finlayson EV, Stukel TA, Lucas FL, Batista I, et al. Hospital volume and surgical mortality in the United States. N Engl J Med. 2002;346(15):1128\u201337.","journal-title":"N Engl J Med"},{"key":"4544_CR15","unstructured":"Chen JH, Wu CW, Lo SS, Li AF, Hsieh MC, Shen KH, et al. Lymph node metastasis as a single predictor in patients with Borrmann type I gastric cancer. Hepatogastroenterology. 2007;54(75):981\u20134."},{"issue":"1","key":"4544_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10120-012-0163-4","volume":"16","author":"A Nashimoto","year":"2013","unstructured":"Nashimoto A, Akazawa K, Isobe Y, Miyashiro I, Katai H, Kodera Y, et al. Gastric cancer treated in 2002 in Japan: 2009 annual report of the JGCA nationwide registry. Gastric Cancer. 2013;16(1):1\u201327.","journal-title":"Gastric Cancer"},{"issue":"10","key":"4544_CR17","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1046\/j.1445-2197.2002.02523.x","volume":"72","author":"DY Kim","year":"2002","unstructured":"Kim DY, Kim HR, Kim YJ, Kim S. Clinicopathological features of patients with Borrmann type IV gastric carcinoma. ANZ J Surg. 2002;72(10):739\u201342.","journal-title":"ANZ J Surg"},{"issue":"4","key":"4544_CR18","doi-asserted-by":"publisher","first-page":"240","DOI":"10.4103\/sjg.sjg_469_22","volume":"29","author":"C Liang","year":"2023","unstructured":"Liang C, Liang Y, Ou B, Yuan L, Yuan S. Clinicopathological and prognostic features of Borrmann type IV gastric cancer versus other Borrmann types: a unique role of signet ring cell carcinoma. Saudi J Gastroenterol. 2023;29(4):240\u201350.","journal-title":"Saudi J Gastroenterol"},{"issue":"9","key":"4544_CR19","doi-asserted-by":"publisher","first-page":"992","DOI":"10.4251\/wjgo.v12.i9.992","volume":"12","author":"Z Zhai","year":"2020","unstructured":"Zhai Z, Zhu ZY, Zhang Y, Yin X, Han BL, Gao JL, et al. Prognostic significance of Borrmann type combined with vessel invasion status in advanced gastric cancer. World J Gastrointest Oncol. 2020;12(9):992\u20131004.","journal-title":"World J Gastrointest Oncol"},{"key":"4544_CR20","doi-asserted-by":"crossref","unstructured":"Song XH, Zhang WH, Kai-Liu, Chen XL, Zhao LY, Chen XZ, Kun-Yang, Zhou ZG, Hu JK. Prognostic impact of Borrmann classification on advanced gastric cancer: a retrospective cohort from a single institution in western China. World J Surg Oncol. 2020;18(1):204.","DOI":"10.1186\/s12957-020-01987-5"},{"issue":"3","key":"4544_CR21","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1007\/s12029-022-00880-6","volume":"54","author":"Y Hirata","year":"2023","unstructured":"Hirata Y, Agnes A, Prakash LR, Mansfield P, Badgwell BD, Ikoma N. Borrmann type predicts response to preoperative therapy in advanced gastric cancer. J Gastrointest Cancer. 2023;54(3):882\u20139.","journal-title":"J Gastrointest Cancer"},{"issue":"28","key":"4544_CR22","doi-asserted-by":"publisher","first-page":"287","DOI":"10.2147\/CEG.S212895","volume":"12","author":"X Dai","year":"2019","unstructured":"Dai X, Zhang X, Yu J. Clinicopathological features and Borrmann classification associated with HER2-positive in primary gastric cancer. Clin Exp Gastroenterol. 2019;12(28):287\u201394.","journal-title":"Clin Exp Gastroenterol"},{"issue":"4","key":"4544_CR23","doi-asserted-by":"publisher","first-page":"336","DOI":"10.5946\/ce.2016.057","volume":"49","author":"K Jung","year":"2016","unstructured":"Jung K, Park MI, Kim SE, Park SJ. Borrmann type 4 advanced gastric cancer: focus on the development of scirrhous gastric cancer. Clin Endosc. 2016;49(4):336\u201345.","journal-title":"Clin Endosc"},{"key":"4544_CR24","doi-asserted-by":"crossref","unstructured":"Y Iwasaki M Sasako S Yamamoto K Nakamura T Sano H Katai, et al Gastric Cancer Surgical Study Group of Japan Clinical Oncology Group 2013 Phase II study of preoperative chemotherapy with S-1 and cisplatin followed by gastrectomy for clinically resectable type 4 and large type 3 gastric cancers (JCOG0210). J Surg Oncol. 2013;107(7):741\u201345","DOI":"10.1002\/jso.23301"},{"key":"4544_CR25","doi-asserted-by":"crossref","unstructured":"M Terashima Y Iwasaki J Mizusawa H Katayama K Nakamura H Katai, et al Stomach Cancer Study Group, Japan Clinical Oncology Group. Randomized phase III trial of gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer, the short-term safety and surgical results: Japan Clinical Oncology Group Study (JCOG0501). Gastric Cancer. 2019;22(5):10441052.","DOI":"10.1007\/s10120-019-00941-z"},{"issue":"8","key":"4544_CR26","doi-asserted-by":"publisher","first-page":"4936","DOI":"10.1245\/s10434-023-13495-3","volume":"30","author":"Y Hirata","year":"2023","unstructured":"Hirata Y, Agnes A, Estrella JS, Blum Murphy M, Das P, Minsky BD, et al. Clinical impact of positive surgical margins in gastric adenocarcinoma in the era of preoperative therapy. Ann Surg Oncol. 2023;30(8):4936\u201345.","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"4544_CR27","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.3390\/cancers12082236","volume":"12","author":"Y Chen","year":"2020","unstructured":"Chen Y, Zhou Q, Wang H, Zhuo W, et al. Predicting peritoneal dissemination of gastric cancer in the era of precision medicine: molecular characterization and biomarkers. Cancers (Basel). 2020;12(8):2236.","journal-title":"Cancers (Basel)"},{"key":"4544_CR28","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1200\/JCO.18.01688","volume":"37","author":"PE Bonnot","year":"2019","unstructured":"Bonnot PE, Piessen G, Kepenekian V, Decullier E, Pocard M, Meunier B, et al. Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastases (CYTO-CHIP study): a propensity score analysis. J Clin Oncol. 2019;37:2028\u201340.","journal-title":"J Clin Oncol"},{"key":"4544_CR29","doi-asserted-by":"crossref","unstructured":"Takao M, Fukuda T, Iwanaga S, Hayashi K, Kusano H, Okudaira S. Gastric cancer: evaluation of triphasic spiral CT and radiologic-pathologic correlation. J Comput Assist Tomogr. 1998;22:288\u2013294","DOI":"10.1097\/00004728-199803000-00024"},{"issue":"3","key":"4544_CR30","doi-asserted-by":"publisher","first-page":"3338","DOI":"10.1038\/srep03338","volume":"26","author":"M Pan","year":"2013","unstructured":"Pan M, Huang P, Li S, Chen J, Wei S, Zhang Y. Double contrast-enhanced ultrasonography in preoperative Borrmann classification of advanced gastric carcinoma: comparison with histopathology. Sci Rep. 2013;26(3):3338.","journal-title":"Sci Rep"},{"issue":"4","key":"4544_CR31","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1136\/gut.49.4.534","volume":"49","author":"S Kelly","year":"2001","unstructured":"Kelly S, Harris KM, Berry E, Hutton J, Roderick P, Cullingworth J, et al. A systematic review of the staging performance of endoscopic ultrasound in gastro-oesophageal carcinoma. Gut. 2001;49(4):534\u20139.","journal-title":"Gut"},{"issue":"7","key":"4544_CR32","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1016\/j.ultrasmedbio.2016.01.030","volume":"42","author":"C Yan","year":"2016","unstructured":"Yan C, Bao X, Shentu W, Chen J, Liu C, Ye Q, et al. Preoperative gross classification of gastric adenocarcinoma: comparison of double contrast-enhanced ultrasound and multi-detector row CT. Ultrasound Med Biol. 2016;42(7):1431\u201340.","journal-title":"Ultrasound Med Biol"},{"issue":"3","key":"4544_CR33","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.artmed.2004.03.003","volume":"31","author":"H Altay G\u00fcvenir","year":"2004","unstructured":"Altay G\u00fcvenir H, Emeksiz N, Ikizler N, Ormeci N. Diagnosis of gastric carcinoma by classification on feature projections. Artif Intell Med. 2004;31(3):231\u201340.","journal-title":"Artif Intell Med"},{"key":"4544_CR34","doi-asserted-by":"crossref","unstructured":"Kapuria S, Bonyun J, Kulkarni Y, Ikoma N, Chinchali S, Alambeigi F.\u00a0Robot-enabled machine learning-based diagnosis of gastric cancer polyps using partial surface tactile imaging. In 2024 IEEE\/RSJ international conference on intelligent robots and systems, IROS 2024. Institute of Electrical and Electronics Engineers Inc. 2024. p. 2360\u2013365.","DOI":"10.1109\/IROS58592.2024.10802585"},{"issue":"2","key":"4544_CR35","first-page":"113","volume":"5","author":"X Huang","year":"2024","unstructured":"Huang X, Qin M, Fang M, Wang Z, Hu C, Zhao T, et al. The application of artificial intelligence in upper gastrointestinal cancers. J Natl Cancer Cent. 2024;5(2):113\u201331.","journal-title":"J Natl Cancer Cent"},{"issue":"9","key":"4544_CR36","doi-asserted-by":"publisher","first-page":"5017","DOI":"10.1002\/mp.15094","volume":"48","author":"S Wang","year":"2021","unstructured":"Wang S, Dong D, Zhang W, Hu H, Li H, Zhu Y, et al. Specific Borrmann classification in advanced gastric cancer by an ensemble multilayer perceptron network: a multicenter research. Med Phys. 2021;48(9):5017\u201328.","journal-title":"Med Phys"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04544-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-04544-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04544-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T03:04:23Z","timestamp":1768359863000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-025-04544-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,9]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4544"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-04544-0","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,9]]},"assertion":[{"value":"17 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the principles of the Declaration of Helsinki (revised 2013). Ethical approval was obtained from the Erzincan Binali Yildirim University Clinical Research Ethics Committee (Decision No: 08\/09\u201321). Informed consent was obtained from all participants or their legal guardians.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20"}}